HomeCEL • LON
add
Celadon Pharmaceuticals PLC
Previous close
GBX 12.50
Day range
GBX 12.00 - GBX 13.00
Year range
GBX 12.00 - GBX 130.00
Market cap
9.62M GBP
Avg Volume
70.16K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 31.50K | 687.50% |
Operating expense | 1.17M | -34.79% |
Net income | -1.20M | 44.36% |
Net profit margin | -3.80K | 92.93% |
Earnings per share | — | — |
EBITDA | -1.02M | 38.80% |
Effective tax rate | 0.50% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.00K | -99.01% |
Total assets | 8.46M | -10.55% |
Total liabilities | 6.01M | -6.49% |
Total equity | 2.45M | — |
Shares outstanding | 64.62M | — |
Price to book | 3.12 | — |
Return on assets | -34.33% | — |
Return on capital | -40.17% | — |
Cash Flow
Net change in cash
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -1.20M | 44.36% |
Cash from operations | -1.29M | 14.03% |
Cash from investing | -13.00K | 87.50% |
Cash from financing | 678.50K | 647.18% |
Net change in cash | -621.50K | 63.97% |
Free cash flow | -684.06K | 30.33% |
About
Founded
2018
Website
Employees
27
